Inrobics is a Spanish startup founded in 2020 with the slogan "Robots for a better quality of life." The company offers a digital platform based on social robotics specifically designed to provide rehabilitation sessions for individuals with limitations in their motor, cognitive, and social capacities resulting from brain damage, neurodevelopmental disorders, or related pathologies. This innovative platform integrates interaction with a humanoid robot, advanced 3D sensor technology, and Artificial Intelligence to provide personalized and effective rehabilitation sessions.
The last recorded investment for Inrobics was a €350.00K Pre-Seed Round investment on 02 August 2022. The investors involved in this round were Grow Venture Partners and Capital Cell, indicating confidence and support from reputable investment firms.
Inrobics is at the forefront of the robotics industry, leveraging cutting-edge technology to make rehabilitation more accessible through digitalization, allowing users to benefit from sessions in the comfort of their homes. The incorporation of gamification, intensification of therapies, neuroplasticity, and motor control principles, in collaboration with skilled therapists, underscores the company's commitment to ensuring the highest quality of care and personalized experience for each user.
The company's innovative use of robotics, AI, and sensor technology highlights its potential to revolutionize the field of rehabilitation and underscores its potential for growth and impact in the healthcare sector.
No recent news or press coverage available for Inrobics.